全文获取类型
收费全文 | 13142篇 |
免费 | 670篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 181篇 |
儿科学 | 264篇 |
妇产科学 | 252篇 |
基础医学 | 1634篇 |
口腔科学 | 708篇 |
临床医学 | 1050篇 |
内科学 | 3161篇 |
皮肤病学 | 257篇 |
神经病学 | 1137篇 |
特种医学 | 288篇 |
外科学 | 2125篇 |
综合类 | 70篇 |
一般理论 | 6篇 |
预防医学 | 870篇 |
眼科学 | 259篇 |
药学 | 767篇 |
中国医学 | 48篇 |
肿瘤学 | 814篇 |
出版年
2023年 | 114篇 |
2022年 | 204篇 |
2021年 | 485篇 |
2020年 | 278篇 |
2019年 | 377篇 |
2018年 | 444篇 |
2017年 | 325篇 |
2016年 | 323篇 |
2015年 | 387篇 |
2014年 | 565篇 |
2013年 | 694篇 |
2012年 | 1133篇 |
2011年 | 1122篇 |
2010年 | 624篇 |
2009年 | 559篇 |
2008年 | 913篇 |
2007年 | 879篇 |
2006年 | 787篇 |
2005年 | 760篇 |
2004年 | 652篇 |
2003年 | 548篇 |
2002年 | 527篇 |
2001年 | 89篇 |
2000年 | 66篇 |
1999年 | 83篇 |
1998年 | 108篇 |
1997年 | 70篇 |
1996年 | 63篇 |
1995年 | 56篇 |
1994年 | 50篇 |
1993年 | 42篇 |
1992年 | 39篇 |
1991年 | 40篇 |
1990年 | 28篇 |
1989年 | 21篇 |
1988年 | 25篇 |
1987年 | 26篇 |
1986年 | 26篇 |
1985年 | 18篇 |
1984年 | 21篇 |
1983年 | 12篇 |
1982年 | 19篇 |
1981年 | 25篇 |
1980年 | 26篇 |
1979年 | 17篇 |
1975年 | 12篇 |
1974年 | 15篇 |
1973年 | 12篇 |
1972年 | 12篇 |
1969年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 609 毫秒
991.
Surgical outcome in 85 patients with primary cardiac tumors 总被引:7,自引:0,他引:7
Bakaeen FG Reardon MJ Coselli JS Miller CC Howell JF Lawrie GM Espada R Ramchandani MK Noon GP Weilbaecher DG DeBakey ME 《American journal of surgery》2003,186(6):641-7; discussion 647
BACKGROUND: We present a large, single institution experience with adult cardiac tumors and address factors affecting outcome. METHODS: A retrospective review was made of all patients who underwent surgery for primary cardiac tumors from April 1975 through August 2002. RESULTS: Eighty-five patients (33 male and 52 female) with a mean age of 54 years were identified with follow-up available for 80 (94%) patients. There were 68 (80%) benign tumors and 17 (20%) malignant tumors. Three tumors recurred and were resected giving a total of 88 surgeries. All benign tumors were grossly resected and the extent of resection for malignant disease ranged from 14 (78%) gross resections and 3 (17%) debulkings to 1 (5%) biopsy. There were 4 (5%) early hospital deaths. Median survival was 9.6 months and 322 months for patients with malignant and benign diseases, respectively. Significant predictors of long-term mortality were malignant disease (P <0.0001) and New York Heart Association class (P <0.03). CONCLUSIONS: Surgical resection provides excellent outcome in patients with benign cardiac tumors. Malignant tumors continue to pose a challenge with good local tumor control but limited survival owing to metastatic disease. 相似文献
992.
993.
994.
995.
996.
Cancer incidence among 10,211 airline pilots: a Nordic study 总被引:5,自引:0,他引:5
Pukkala E Aspholm R Auvinen A Eliasch H Gundestrup M Haldorsen T Hammar N Hrafnkelsson J Kyyrönen P Linnersjö A Rafnsson V Storm H Tveten U 《Aviation, space, and environmental medicine》2003,74(7):699-706
BACKGROUND: Commercial airline pilots are exposed to cosmic radiation and other potentially carcinogenic elements during work and leisure activities. HYPOTHESIS: Work-related factors affect cancer pattern of the pilots. METHODS: A cohort of 10,051 male and 160 female airline pilots from Denmark, Finland, Iceland, Norway, and Sweden was followed for cancer incidence through the national cancer registries. There were 177,000 person-years at follow-up, 51,000 of them accumulated after 20 yr since the time of first employment. Standardized incidence ratios (SIRs) were defined as ratios of observed over expected numbers of cases based on national cancer incidence rates. Dose-response analyses were done with Poisson regression method. RESULTS: Among male pilots, there were 466 cases of cancer diagnosed vs. 456 expected. The only significantly increased SIRs concerned skin cancer: melanoma 2.3 (95% CI 1.7-3.0), squamous cell cancer 2.1 (1.7-2.8), and basal cell carcinoma 2.5 (1.9-3.2). The relative risk of skin cancers increased with the time since first employment, the number of flight hours, and the estimated radiation dose. There was an increase in the relative risk of prostate cancer with increasing number of flight hours in long-distance aircraft (p trend 0.01). No increased incidence was found for acute myeloid leukemia or brain cancer which were of interest a priori based on earlier studies. CONCLUSIONS: This large study, based on reliable cancer incidence data, showed an increased incidence of skin cancer. It did not indicate a marked increase in cancer risk attributable to cosmic radiation although some influence of cosmic radiation on skin cancer cannot be entirely excluded. 相似文献
997.
Matrix metalloproteinase (MMP)-9 (gelatinase B) belongs to the MMP family of zinc-dependent endopeptidases that has been associated with tumor cell invasion and metastasis and tumor-induced angiogenesis. As a secreted MMP, pro-MMP-9 is released into the extracellular environment by both tumor and stroma cells, where it fulfills its proteolytic functions degrading both extracellular matrix (ECM) and non-ECM proteins. A major dilemma in our understanding of MMP-9 function is how the released protease is targeted to the right location and how its activity is controlled at the pericellular space. It has been proposed that MMP-9 interact with cell surface components and that this type of interaction positively regulates enzymatic activation and activity. However, recent evidence shows that association of MMP-9 with the cell surface is mediated by a distinct array of surface proteins that serve to regulate multiple aspects of the enzyme function including localization, inhibition and internalization. How these distinct mechanisms regulate the overall MMP-9 activity at the pericellular space remains an important goal in our understanding of MMP-9 function at the cell surface. Furthermore, the study of surface-associated MMP-9 imposes new conceptual and methodological challenges with particular consideration to the unique structural and functional characteristics of this key enzyme. 相似文献
998.
Kagan BL Henke RT Cabal-Manzano R Stoica GE Nguyen Q Wellstein A Riegel AT 《Cancer research》2003,63(7):1696-1705
The fibroblast growth factor-binding protein (FGF-BP) binds and activates fibroblast growth factors in the extracellular matrix, and can have a rate-limiting role in tumor angiogenesis. Here we demonstrate high levels of FGF-BP expression in invasive human breast cancer, relative to normal breast and in situ carcinoma, and in MDA-MB-468 human breast cancer cells. In these cells, FGF-BP was up-regulated by treatment with epidermal growth factor (EGF), dependent on protein kinase C and p38 mitogen-activated protein kinase signaling. Mutational analysis revealed that the activator protein 1 and CCAAT/enhancer binding protein (C/EBP) sites on the FGF-BP gene promoter were required for the EGF effect, whereas deletion of the C/EBP site resulted in a significant increase in promoter basal activity indicating a basal repressive control mechanism. These data suggest that the C/EBP site is a central regulatory element for the regulation of FGF-BP promoter activity in MDA-MB-468 cells. We found that MDA-MB-468 cells express high endogenous levels of both the activating (LAP) and repressive (LIP) isoforms of C/EBPbeta. Overexpression of C/EBPbeta-LAP in MDA-MB-468 cells resulted in a large 80-fold increase in FGF-BP promoter basal activity, which was reversed by coexpression of LIP. Gel-shift analysis revealed that four LIP- and LAP-containing complexes (a-d) bind to the C/EBP site. DNA binding of the LIP and LAP-containing c complex and the b complex in the presence of EGF was modulated by inhibition of p38 mitogen-activated protein kinase, suggesting a role for these complexes in the EGF induction of the FGF-BP promoter. This study suggests that along with its well-defined role in mammary gland development, C/EBPbeta may well play a role in the pathology of breast cancer, in particular in the control of angiogenesis in the invasive phenotype. 相似文献
999.
1000.
Ajoene,a garlic compound,inhibits protein prenylation and arterial smooth muscle cell proliferation 总被引:3,自引:0,他引:3
Ferri N Yokoyama K Sadilek M Paoletti R Apitz-Castro R Gelb MH Corsini A 《British journal of pharmacology》2003,138(5):811-818
(1) Ajoene is a garlic compound with anti-platelet properties and, in addition, was shown to inhibit cholesterol biosynthesis by affecting 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase and late enzymatic steps of the mevalonate (MVA) pathway. (2) MVA constitutes the precursor not only of cholesterol, but also of a number of non-sterol isoprenoids, such as farnesyl and geranylgeranyl groups. Covalent attachment of these MVA-derived isoprenoid groups (prenylation) is a required function of several proteins that regulate cell proliferation. We investigated the effect of ajoene on rat aortic smooth muscle cell proliferation as related to protein prenylation. (3) Cell counting, DNA synthesis, and cell cycle analysis showed that ajoene (1-50 micro M) interfered with the progression of the G1 phase of the cell cycle, and inhibited rat SMC proliferation. (4) Similar to the HMG-CoA reductase inhibitor simvastatin, ajoene inhibited cholesterol biosynthesis. However, in contrast to simvastatin, the antiproliferative effect of ajoene was not prevented by the addition of MVA, farnesol (FOH), and geranylgeraniol (GGOH). Labelling of smooth muscle cell cellular proteins with [3H]-FOH and [3H]-GGOH was significantly inhibited by ajoene. (5) In vitro assays for protein farnesyltransferase (PFTase) and protein geranylgeranyltransferase type I (PGGTase-I) confirmed that ajoene inhibits protein prenylation. High performance liquid chromatography (HPLC) and mass spectrometry analyses also demonstrated that ajoene causes a covalent modification of the cysteine SH group of a peptide substrate for protein PGGTase-I. (6) Altogether, our results provide evidence that ajoene interferes with the protein prenylation reaction, an effect that may contribute to its inhibition of SMC proliferation. 相似文献